(Q34460043)

2 August 2017

title

Prospective genetic profiling of squamous cell lung cancer and adenosquamous carcinoma in Japanese patients by multitarget assays (English)

1 reference

2 August 2017

main subject

adenosquamous carcinoma

1 reference

Hirotsugu Kenmotsu

1

1 reference

2 August 2017

Masakuni Serizawa

2

1 reference

2 August 2017

Yasuhiro Koh

3

1 reference

2 August 2017

Mitsuhiro Isaka

4

1 reference

2 August 2017

Toshiaki Takahashi

5

1 reference

2 August 2017

Tetsuhiko Taira

6

1 reference

2 August 2017

Akira Ono

7

1 reference

2 August 2017

Tomohiro Maniwa

8

1 reference

2 August 2017

Shoji Takahashi

9

1 reference

2 August 2017

Keita Mori

10

1 reference

2 August 2017

Masahiro Endo

11

1 reference

2 August 2017

Masato Abe

12

1 reference

2 August 2017

Isamu Hayashi

13

1 reference

2 August 2017

Takashi Nakajima

14

1 reference

2 August 2017

Yasuhisa Ohde

15

1 reference

2 August 2017

Nobuyuki Yamamoto

16

1 reference

2 August 2017

language of work or name

English

0 references

publication date

28 October 2014

1 reference

2 August 2017

1 reference

2 August 2017

volume

14

1 reference

2 August 2017

page(s)

786

1 reference

Integrative and comparative genomic analysis of lung squamous cell carcinomas in East Asian patients

2 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4221703

New targets in non-small cell lung cancer

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4221703

Crizotinib versus chemotherapy in advanced ALK-positive lung cancer.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4221703

Mutation incidence and coincidence in non small-cell lung cancer: meta-analyses by ethnicity and histology (mutMap).

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4221703

New targetable oncogenes in non-small-cell lung cancer

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4221703

Fibroblast growth factor receptor 1 gene amplification is associated with poor survival and cigarette smoking dosage in patients with resected squamous cell lung cancer.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4221703

FGFR1 amplification in squamous cell carcinoma of the lung

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4221703

Squamous-cell carcinomas of the lung: emerging biology, controversies, and the promise of targeted therapy

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4221703

Comprehensive genomic characterization of squamous cell lung cancers

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4221703

Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4221703

Molecular pathways: fibroblast growth factor signaling: a new therapeutic opportunity in cancer

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4221703

Whole cancer genome sequencing by next-generation methods

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4221703

New driver mutations in non-small-cell lung cancer

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4221703

A platform for rapid detection of multiple oncogenic mutations with relevance to targeted therapy in non-small-cell lung cancer

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4221703

Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4221703

Gefitinib or chemotherapy for non-small-cell lung cancer with mutated EGFR

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4221703

Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): an open label, randomised phase 3 trial

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4221703

Genetic alterations in the phosphoinositide 3-kinase/Akt signaling pathway confer sensitivity of thyroid cancer cells to therapeutic targeting of Akt and mammalian target of rapamycin

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4221703

Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4221703

PIK3CA mutations and copy number gains in human lung cancers

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4221703

Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancer

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4221703

Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4221703

Assessment of mutational profile of Japanese lung adenocarcinoma patients by multitarget assays: a prospective, single-institute study

6 July 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-14-786

Multiple genetic alterations in papillary thyroid cancer are associated with younger age at presentation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-14-786

Genetic alterations of K-ras may reflect prognosis in stage III colon cancer patients below 60 years of age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-14-786

Impact of age on epidermal growth factor receptor mutation in lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-14-786

Increased FGFR1 copy number in lung squamous cell carcinomas.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4221703

Effect of cigarette smoking on major histological types of lung cancer: a meta-analysis

27 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25348872

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

PIK3CA mutation status in Japanese lung cancer patients

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25348872

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1186/1471-2407-14-786

1 reference

Dimensions Publication ID

2 August 2017

0 references

1 reference

2 August 2017

1 reference